Home › Opioid Overdose › NCT07169409
Right Tools, Right Time, Right Place: Telehealth for Opioid Use Disorder in Vulnerable Settings
RecruitingPhase 1
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * History of Opioid Use Disorder (OUD) * Starting OUD treatment with buprenorphine, or within 45 days of starting or restarting this medication * Speak and understand English Exclusion Criteria: * History of allergic reaction to buprenorphine * Plans to move out of a Boulder Care-affiliated state site in the next 12 months (precluding continuation of care) * Untreated mental or medical health conditions that, in the opinion of the participant, would preclude study participation
About the study
Our primary objective is to evaluate the ability of Boulder Care's telehealth-platform to create the necessary paradigmatic shift in Opioid Use Disorder (OUD) treatment to reach vulnerable populations, with targets that support both equitable and culturally-specific OUD treatment as well as business profitability.
What is being tested
- Telemedicine Buprenorphine Treatment (drug)
Sponsor: Boulder Care · Participants: 250 · Started: Jun 10, 2025
Contact the study team
- Andrea Baron, MPH · Phone: 408-483-2766
- Laura Monico, PhD · Phone: 855-605-8816
Official record on ClinicalTrials.gov — NCT07169409
Locations in the U.S.
| Oregon | Boulder Care, Portland |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.